Purpose <p>Previous studies in healthy individuals showed that high-frequency but not the low frequency non-invasive vagal nerve stimulation improves olfactory function in healthy individuals. The present study aimed to analyze the potential effects of non-invasive, high-frequency transcutaneous auricular vagal nerve stimulation (TA-VNS) on olfactory function in patients with olfactory dysfunction (OD) and healthy individuals.</p> Methods <p>Patients with post-COVID-19 associated OD (<i>n</i> = 10) and normosmic individuals (<i>n</i> = 30) performed olfactory testing (Sniffin` Sticks), trigeminal testing (lateralization test), attentional tests (d2 test), ratings of odor intensity and pleasantness before and after receiving a TA-VNS for 10&#xa0;min. Patients with OD received only TA-VNS while normosmic subjects underwent, in addition to TA-VNS, placebo stimulation (control condition) with electrode placement of TA-VNS, and active-control transcutaneous stimulation at the forearm in a randomized order with a minimum 24-h interval between sessions.</p> Results <p>In patients with OD intensity ratings for fish and pleasantness ratings for eucalyptol increased and olfactory discrimination improved (<i>p</i> = 0.017) as opposed to olfactory threshold (<i>p</i> = 0.18). For both, patients with OD and healthy individuals results of the d2 attention test improved following the TA-VNS. In healthy individuals, there were no differences in olfactory discrimination nor threshold regarding the 3 stimulation modalities (TA-VNS, placebo (control condition), transcutaneous stimulation).</p> Conclusion <p>These results seem to underline the functional connection of the olfactory system with the afferent vagus network. However, a ceiling effect for olfactory discrimination did not allow to observe a possible improvement in normosmic individuals. Further studies in patients with OD are needed to characterize this potential therapeutic effect of TA-VNS.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Improved olfactory function following high-frequency transcutaneous auricular vagal nerve stimulation in post-COVID-19 patients with olfactory dysfunction

  • Susanne Weise,
  • Mária Oravcová,
  • Pauline Hanslik,
  • Coralie Mignot,
  • Yusuf Ozgur Cakmak,
  • Thomas Hummel

摘要

Purpose

Previous studies in healthy individuals showed that high-frequency but not the low frequency non-invasive vagal nerve stimulation improves olfactory function in healthy individuals. The present study aimed to analyze the potential effects of non-invasive, high-frequency transcutaneous auricular vagal nerve stimulation (TA-VNS) on olfactory function in patients with olfactory dysfunction (OD) and healthy individuals.

Methods

Patients with post-COVID-19 associated OD (n = 10) and normosmic individuals (n = 30) performed olfactory testing (Sniffin` Sticks), trigeminal testing (lateralization test), attentional tests (d2 test), ratings of odor intensity and pleasantness before and after receiving a TA-VNS for 10 min. Patients with OD received only TA-VNS while normosmic subjects underwent, in addition to TA-VNS, placebo stimulation (control condition) with electrode placement of TA-VNS, and active-control transcutaneous stimulation at the forearm in a randomized order with a minimum 24-h interval between sessions.

Results

In patients with OD intensity ratings for fish and pleasantness ratings for eucalyptol increased and olfactory discrimination improved (p = 0.017) as opposed to olfactory threshold (p = 0.18). For both, patients with OD and healthy individuals results of the d2 attention test improved following the TA-VNS. In healthy individuals, there were no differences in olfactory discrimination nor threshold regarding the 3 stimulation modalities (TA-VNS, placebo (control condition), transcutaneous stimulation).

Conclusion

These results seem to underline the functional connection of the olfactory system with the afferent vagus network. However, a ceiling effect for olfactory discrimination did not allow to observe a possible improvement in normosmic individuals. Further studies in patients with OD are needed to characterize this potential therapeutic effect of TA-VNS.